TWINSTRAND THERAPEUTICS

Twinstrand Therapeutics is a biopharmaceutical company that engages in the discovery, development, and commercialization of biological drugs for the treatment of life-threatening diseases. The product of the company is TST10088. It is a recombinant protein-based prodrug for activation by matrix metalloproteinases associated with solid tumor forms of cancer. Twinstrand is a Canada-based company that was founded in 1995. The company was acquired by Cangene on July 7, 2009.

#Financial #Website #More

TWINSTRAND THERAPEUTICS

Industry:

Biotechnology Health Care Information Technology Medical

Founded:

1995-01-01

Address:

Burnaby, British Columbia, Canada

Country:

Canada

Website Url:

http://www.twinstrand.com

Status:

Closed

Contact:

866-300-7602

Total Funding:

10 M CAD

Technology used in webpage:

Network Solutions DNS Hostway

Investors List

western-technology-investment_image

Western Technology Investment

Western Technology Investment investment in Venture Round - Twinstrand Therapeutics

mds-capital_image

MDS Capital

MDS Capital investment in Venture Round - Twinstrand Therapeutics

growthworks_image

GrowthWorks Capital

GrowthWorks Capital investment in Venture Round - Twinstrand Therapeutics

ensis-growth-fund_image

Ensis Growth Fund

Ensis Growth Fund investment in Venture Round - Twinstrand Therapeutics

Official Site Inspections

http://www.twinstrand.com

Host Informations
Whois Informations

Loading ...

More informations about "Twinstrand Therapeutics" on Search Engine